Bank of New York Mellon’s Oyster Point Pharma, Inc. Common Stock OYST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-10,834
| Closed | -$61K | – | 4582 |
|
|
2022
Q3 | $61K | Buy |
+10,834
| New | +$61K | ﹤0.01% | 4290 |
|
|
2022
Q2 | – | Sell |
-39,209
| Closed | -$456K | – | 4744 |
|
|
2022
Q1 | $456K | Buy |
39,209
+2,448
| +7% | +$28.5K | ﹤0.01% | 3762 |
|
|
2021
Q4 | $672K | Buy |
36,761
+569
| +2% | +$10.4K | ﹤0.01% | 3612 |
|
|
2021
Q3 | $428K | Buy |
36,192
+2,331
| +7% | +$27.6K | ﹤0.01% | 3894 |
|
|
2021
Q2 | $582K | Buy |
33,861
+12,834
| +61% | +$221K | ﹤0.01% | 3698 |
|
|
2021
Q1 | $385K | Sell |
21,027
-2,001
| -9% | -$36.6K | ﹤0.01% | 3820 |
|
|
2020
Q4 | $434K | Buy |
23,028
+1,272
| +6% | +$24K | ﹤0.01% | 3685 |
|
|
2020
Q3 | $459K | Buy |
21,756
+2,736
| +14% | +$57.7K | ﹤0.01% | 3533 |
|
|
2020
Q2 | $549K | Sell |
19,020
-1,052
| -5% | -$30.4K | ﹤0.01% | 3426 |
|
|
2020
Q1 | $703K | Buy |
20,072
+9,567
| +91% | +$335K | ﹤0.01% | 3199 |
|
|
2019
Q4 | $257K | Buy |
+10,505
| New | +$257K | ﹤0.01% | 3842 |
|